<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.46149.003</object-id><label>Table 1.</label><caption><title>Vaccines and inflammatory agents.</title><p>The vaccines, TLR agonists, adjuvant and saline used in the present study are detailed. Vaccines were administered by injection of 1/10th the human dose in a 50 &#181;L volume. TLR agonists, IFA and saline were also given in a single 50 &#181;L volume. All injections were into the mouse hind leg quadriceps muscle.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Vaccine/TLR</th><th valign="top">Components</th><th valign="top">Abbreviation</th><th valign="top">Manufacturer</th></tr></thead><tbody><tr><td valign="top">Pentavac SD</td><td valign="top">Diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and haemophilus type b conjugate vaccine</td><td valign="top">Pentavac</td><td valign="top">Serum Institute India</td></tr><tr><td valign="top">Agrippal</td><td valign="top">Trivalent flu subunits &#8211; H3N2, H1N1 and influenza B</td><td valign="top">Tri-Flu</td><td valign="top">Seqirus</td></tr><tr><td valign="top">Fluad</td><td valign="top">Trivalent flu subunits &#8211; H3N2, H1N1 and influenza B&#160;+&#160;MF59</td><td valign="top">Tri-Flu&#160;+&#160;MF59</td><td valign="top">Seqirus</td></tr><tr><td valign="top">Engerix B</td><td valign="top">Recombinant hepatitis B sAg absorbed on alum</td><td valign="top"/><td valign="top">GlaxoSmithKline</td></tr><tr><td valign="top">IFA</td><td valign="top">Montanide ISA 51 VG</td><td valign="top"/><td valign="top">Seppic</td></tr><tr><td valign="top">LPS</td><td valign="top">LPS-EB Ultrapure</td><td valign="top"/><td valign="top">Invivogen</td></tr><tr><td valign="top">Poly I:C</td><td valign="top">Polyinosinic:polycytidylic acid</td><td valign="top"/><td valign="top">Sigma</td></tr></tbody></table></table-wrap>